<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00390065</url>
  </required_header>
  <id_info>
    <org_study_id>MRAP060308</org_study_id>
    <nct_id>NCT00390065</nct_id>
  </id_info>
  <brief_title>Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely</brief_title>
  <official_title>Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely With Respiratory and Neurodevelopmental Impact of Early Treatment With Inhaled Nitric Oxide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maternite Regionale Universitaire</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maternite Regionale Universitaire</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Utilization of nitric oxide (NO) therapy has been related to a trend towards short term
      improvement in very premature infants. A two year follow-up of children treated soon after
      birth with NO in the neonatal period, suggests that a significant improvement in
      neurodevelopmental outcome might occur. This study aims to evaluate follow-up at 6 years, in
      respiratory and neurodevelopmental outcome, of children born very prematurely, some of them
      having been treated with nitric oxide in the neonatal period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Utilization of nitric oxide therapy in the neonatal period has been related to a trend
      towards short term improvements in respiratory and neurological outcome at 28 days postnatal
      age or 36 weeks postconceptional age. A two year follow-up in children treated soon after
      birth with NO in the neonatal period, suggests that a significant improvement in
      neurodevelopmental outcome might occur. No long term evaluation on respiratory outcome has
      yet been done. This study aims to evaluate respiratory and neurodevelopmental outcome at 6
      years of age in children born very prematurely, some of them having had Nitric Oxide as a
      rescue treatment for respiratory distress syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a follow-up study, at 6 years of age, of infants randomized in the neonatal period with one other group studied as a reference group (ie 3 groups)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomization in the neonatal period. Blinding maintained at the time of the follow-up study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary Function testing</measure>
    <time_frame>at 7 years postnatal age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental and Cognitive outcomes</measure>
    <time_frame>at 7 years of age</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hypoxemic Respiratory Failure treated by Nitric Oxide;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hypoxemic Respiratory Failure control (Placebo);</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Reference (Non hypoxemic respiratory failure)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitric Oxide</intervention_name>
    <description>Early low dose (5ppm) NO inhalation Placebo</description>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Reference group (non hypoxemic infants)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All infants included at birth in a randomized controlled trial using early nitric
             oxide therapy

        Exclusion Criteria:

          -  Parental refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel HASCOET, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of NANCY, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle RM HAMON, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternite Regionale Universitaire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maternite Regionale Universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Brabois</name>
      <address>
        <city>Vandoeuvre</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.maternite.chu-nancy.fr</url>
    <description>(home page of the hospital)</description>
  </link>
  <reference>
    <citation>Hascoet JM, Fresson J, Claris O, Hamon I, Lombet J, Liska A, Cantagrel S, Al Hosri J, Thiriez G, Valdes V, Vittu G, Egreteau L, Henrot A, Buchweiller MC, Onody P. The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr. 2005 Mar;146(3):318-23.</citation>
    <PMID>15756211</PMID>
  </reference>
  <reference>
    <citation>Deforge H, André M, Hascoët JM, Toniolo AM, Demange V, Fresson J. [Cognitive development and attention performances at school age of &quot;normal&quot; prematurely born children]. Arch Pediatr. 2006 Sep;13(9):1195-201. Epub 2006 Jul 7. French.</citation>
    <PMID>16824742</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2006</study_first_submitted>
  <study_first_submitted_qc>October 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2006</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maternite Regionale Universitaire</investigator_affiliation>
    <investigator_full_name>Jean Michel Hascoet</investigator_full_name>
    <investigator_title>Professor - Head of Division</investigator_title>
  </responsible_party>
  <keyword>Follow-up</keyword>
  <keyword>Premature infants</keyword>
  <keyword>Nitric Oxide</keyword>
  <keyword>Respiratory function testing</keyword>
  <keyword>Neurodevelopmental outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

